证券代码：002758 证券简称：浙农股份 公告编号：2023-083 号 浙农集团股份有限公司 关于重大资产重组限售股份解除限售上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 4、本次申请解除股份限售的股东在解除限售后，将自觉遵守《上市公司股 东、董监高减持股份的若干规定》《深圳证券交易所上市公司股东及董事、监事、 高级管理人员减持股份实施细则》以及《上市公司董事、监事和高级管理人员所 持本公司股份及其变动管理规则》等相关规定。 特别提示： 1、本次解除限售的股份数量为 277,835,875 股，占公司总股本的 53.17%， 系公司 2020 年重大资产重组发行股份购买资产时向特定对象发行的有限售条件 股份。 2、本次申请解除股份限售的股东 20 名，共对应 20 个证券账户，发行时承 诺的限售期为自相关股份发行结束之日起 36 个月。 3、本次限售股份可上市流通日为 2023 年 11 月 30 日。 本次解除限售的股东为浙农控股、泰安泰、兴合集团、兴合创投、李盛梁等 16 名自然人共 20 名股东，解禁的限售股份数量合计为 27 ...

浙农集团股份有限公司 2023 年第三季度报告 证券代码：002758 证券简称：浙农股份 公告编号：2023-079 号 浙农集团股份有限公司 2023 年第三季度报告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的 真实、准确、完整。 | 润(元) | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 归属于上 | | | | | | | | | | 市公司股 | | | | | | | | | | 东的扣除 | 52,256,223. | 126,767.80 | 125.809.40 | | 200.639.85 | 369.136.96 | 367,259,27 | | | 非经常性 | | 2.4 ...

证券代码：002758 证券简称：浙农股份 浙农集团股份有限公司投资者关系活动记录表 编号：2023-03 □特定对象调研 □分析师会议 投资者关系活动 □媒体采访  业绩说明会 类别 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及 全体投资者 人员姓名 时间 2023年9 月26日 15:00-16:30 地点 深圳证券交易所互动易平台云访谈栏目 上市公司接待人 董事长叶伟勇先生；总经理曾跃芳先生；副总经理、财务总监 员姓名 兼董事会秘书刘文琪先生；独立董事黄祖辉先生 1、看了下公司 2023 年半年度报告，从财务数据看公司 2023 年上半年营收略有增长，但净利润下滑明显，公司为什 么会呈现增收不增利的情况？ 您好！2023 年上半年，公司实现营业收入 196.82 亿元， 同比增长0.36%，实现归母净利润1.77亿元，同比下降33.24%。 ...

浙农集团股份有限公司 ZJAMP Group Co., Ltd. 2023 年半年度报告 2023 年 8 月 浙农集团股份有限公司 2023 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人包中海、主管会计工作负责人刘文琪及会计机构负责人(会计 主管人员)王珏莹声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本年度报告已按照《深圳证券交易所上市公司自律监管指引第 3 号——行 业信息披露》第七章 零售业的要求进行了披露。公司请投资者认真阅读本半 年度报告全文，并特别注意下列风险因素：产业政策变化风险、市场竞争加 剧风险、客户需求发生变化风险、经营产品质量与品牌声誉风险、经营产品 价格波动风险、异常天气、自然灾害或汇率变动等风险、投资项目风险等， 有关风险因素及应对措施已在本报告第三节"管理层讨论与分析"中"十、公司 面临的风险和应对措施"部分予以描述。本报告中涉及未来计划等前瞻性陈述， 公司 ...

证券代码：002758 证券简称：浙农股份 编号：2023-02 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系活动 □新闻发布会 □路演活动 类别 现场参观 □其他 （请文字说明其他活动内容） 东北证券：许啸天、蔡文清、朱学远、杨曌；杭州紫外线私募 基金有限公司：张宇、王少、章洁；杭州翼融资产管理有限公 司：宋进；杭州润洲投资管理有限公司：徐辉；上海追燊管理 咨询有限公司：胡彬；浙江赢之川投资管理有限公司：张波、 侯放；浙江言信资产管理有限公司：沈梦凯；浙商国际金融控 参与单位名称及 股有限公司：诸丛欣；杭州艮岳私募基金管理有限公司：陆洲； 人员姓名 浙江探骊私募基金有限公司：陈法非、林阳相、曾平安；杭州 波粒二象资产管理有限公司：辜敏；浙江臻博睿资产管理有限 公司：蒋加习；杭州点将台投资管理有限公司：王泽楷；中盛 晨嘉（深圳）私募证券基金管理有限公司：戴维、楼逸君；杭 州潮生科技有限公司：姜婷；浙江朔盈资产管理有限公司：李 小鹏；上海晓著投资有限公司：施政；高净值投资者：徐腾飞 时间 2023 年 6 月 21 日 14:00-16:00 地点 公司会议室 上市公司接待人 员姓名 副总经 ...

证券代码：002758 证券简称：浙农股份 | --- | --- | --- | --- | |----------------|---------------|----------------------------|---------| | | | | 2023-01 | | | □特定对象调研 | □分析师会议 | | | 投资者关系活动 | □媒体采访 | 业绩说明会 | | | 类别 | □新闻发布会 | 路演活动 | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称及 | | | | | | 全体投资者 | | | 人员姓名 时间 2023 年 5 月 12 日 15:00-17:00 地点 全景网网上路演中心 上市公司接待人 董事长包中海先生、董事兼常务副总经理曾跃芳先生、副总经 员姓名 理兼财务总监刘文琪先生、副总经理兼董事会秘书金鼎先生、 独立董事郭德贵先生 1、浙农真的适合我们普通投资者投资吗？看不到亮点哦。 请董事长结合年报情况，讲讲我们去年浙农业绩和业务上有哪 些亮点？ 您好！公司近三年规模效益稳步发展，2022 年实现营业 ...

证券代码：002758 证券简称：浙农股份 公告编号：2023-046号 浙农集团股份有限公司 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日活动 暨举办 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，浙农集团股份有限公司（以下简称"公 司"）将参加由浙江证监局、浙江省上市公司协会与深圳市全景网络有限公司联 合举办的"2023 年浙江辖区上市公司投资者集体接待日活动"，现将相关事项公 告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流，活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时，公 司董事长包中海先生、董事兼常务副总经理曾跃芳先生、副总经理兼财务总监刘 文琪先生、副总经理兼董事会秘书金鼎先生、独立董事郭德贵先生，将在线就公 司 2022 年度业绩、公司治理、发展战略、经营状况、融资计划、股权激励和可 持续发展等投资 ...

浙农集团股份有限公司 2023 年第一季度报告 证券代码：002758 证券简称：浙农股份 公告编号：2023-044 号 浙农集团股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 □会计政策变更 □会计差错更正 同一控制下企业合并 □其他原因 | | 本报告期 | 上年同期 | | 本报告期比上年同期 增减（%） | | --- | --- | --- | --- | --- | | | | 调整前 | 调整后 | 调整后 | | 营业收入（元） | 10,211,322,413.10 | 9,469,580,257.41 | 9,470,07 ...

Financial Performance - Revenue for 2022 reached 41.81 billion yuan, an increase of 18.97% compared to the adjusted revenue of 35.15 billion yuan in 2021[1] - Net profit attributable to shareholders decreased by 7.11% to 609.79 million yuan in 2022 from the adjusted 656.50 million yuan in 2021[1] - Revenue for Q1 2022 was 9.47 billion yuan, Q2 was 10.14 billion yuan, Q3 was 11.24 billion yuan, and Q4 was 10.96 billion yuan[28] - Net profit attributable to shareholders in Q1 was 139.94 million yuan, Q2 was 126.52 million yuan, Q3 was 143.38 million yuan, and Q4 was 199.95 million yuan[28] - Total assets at the end of 2022 were 19.50 billion yuan, a 19.47% increase compared to the previous year[30] - Net assets attributable to shareholders at the end of 2022 were 4.11 billion yuan, a 14.31% increase compared to the previous year[30] - Operating cash flow for 2022 was 1.97 billion yuan, a 43.75% increase compared to the previous year[30] - Basic earnings per share for 2022 was 1.24 yuan, a decrease of 8.15% compared to the previous year[30] - Diluted earnings per share for 2022 was 1.20 yuan, a decrease of 8.40% compared to the previous year[30] - Weighted average return on equity for 2022 was 15.82%, a decrease of 4.20% compared to the previous year[30] - Net profit attributable to shareholders after deducting non-recurring gains and losses for Q1 was 126.97 million yuan, Q2 was 115.40 million yuan, Q3 was 126.77 million yuan, and Q4 was 189.50 million yuan[34] - Operating cash flow for Q1 was 1.32 billion yuan, Q2 was -608.95 million yuan, Q3 was 1.07 billion yuan, and Q4 was 183.40 million yuan[34] - Non-current asset disposal gains amounted to 380.03 million in 2022, a significant increase from 208.22 million in 2021 and 273.33 million in 2020[35] - Government subsidies recognized in current profits were 419.14 million in 2022, up from 224.12 million in 2021 and 98.12 million in 2020[35] - Investment management gains reached 546.17 million in 2022, slightly higher than 525.31 million in 2021 and significantly above 163.55 million in 2020[35] - Fair value changes of financial assets resulted in a loss of 65.91 million in 2022, compared to a gain of 416.35 million in 2021 and 61.03 million in 2020[35] - Other non-operating income and expenses totaled 50.50 million in 2022, down from 109.04 million in 2021 and a loss of 22.69 million in 2020[35] - Total non-recurring gains and losses were 511.56 million in 2022, decreased from 597.53 million in 2021 and 3.07 billion in 2020[35] - The company raised 2.24 billion through convertible bonds in 2018, with net proceeds of 2.18 billion after deducting issuance costs[40] - Derivative investments for hedging purposes resulted in a fair value loss of 1.84 million in the reporting period[41] - The company strictly follows hedging principles for foreign exchange and commodity futures, avoiding speculative transactions[41] - Risk control measures include close market monitoring, credit management systems, and strict internal control procedures for hedging activities[41] - The company plans to use up to 120 million yuan of temporarily idle raised funds for cash management, limited to purchasing financial products with a maturity of no more than 12 months, high safety, good liquidity, and capital preservation agreements[42][43] - The total raised funds for the initial public offering amounted to 252.56 million yuan, with a net amount of 220.98 million yuan after deducting issuance-related expenses[43] - As of the end of 2022, the cumulative use of raised funds was 177.70 million yuan, with a net interest income of 13.67 million yuan after deducting handling fees, and the remaining balance in the raised funds account was 46.50 million yuan[43] - The company's pharmaceutical logistics phase II construction project and pharmaceutical wholesale business expansion project have been completed and permanently supplemented working capital, while the chain pharmacy expansion project has been changed to a digital system upgrade construction project[43] - The company's R&D investment in 2022 was RMB 18,044,858.29, a 33.20% increase compared to 2021[46] - The number of R&D personnel in 2022 was 61, a 1.67% increase from 2021, with the proportion of R&D personnel accounting for 0.95% of the total workforce[46] - The company's operating cash flow in 2022 was RMB 1,968,797,647.35, a 43.75% increase year-over-year, driven by increased sales collections in the agricultural services business[47] - The net cash flow from investment activities in 2022 was RMB 506,222,782.36, a 272.91% increase compared to 2021, mainly due to reduced financial product purchases[47] - The net cash flow from financing activities in 2022 was -RMB 918,551,658.86, a 124.99% decrease year-over-year, primarily due to a reduction in short-term borrowing[47] - The company's subsidiary, Zhejiang Jinchang Automobile Group, generated revenue of RMB 13,177,138,446.53 in 2022, with a net profit of RMB 539,032,887.43[48] - The company plans to accelerate the construction of high-standard farmland and soil improvement projects, focusing on the EPCO model and replicable innovative models[49] - The company's "Digital System Upgrade Construction Project" aims to enhance operational efficiency and management capabilities by upgrading existing ERP systems and adding new modules[45] - The company's "Medical Logistics Phase II Project" and "Pharmaceutical Wholesale Business Expansion Project" have reached over 96% completion, with remaining funds to be used for working capital[45] - The company's R&D projects include the development of seaweed-based compound microbial fertilizers, traditional Chinese medicine formulas, and formula granules, expected to increase product categories and sales[46] - The company established 32 new subsidiaries in 2022, including agricultural technology, automotive services, and ecological fertilizer companies, with no significant impact on overall production and operations[52] - The company plans to use up to 120 million yuan of temporarily idle raised funds for cash management, limited to purchasing high-security, high-liquidity, and principal-guaranteed financial products with a maturity of no more than 12 months[55] - The company aims to build a new agricultural social service system with a "provincial service platform + regional service centers + grassroots service outlets" model, focusing on resource construction, terminal network connection, technology integration, and digital management empowerment[53] - The company is exploring a full-chain model for traditional Chinese medicine, including seed breeding, planting management, harvesting, processing, and sales, with a focus on promoting the high-quality development of the industry[54] - The company is transforming its automotive business by tracking new energy vehicle technology changes and improving 4S store management through digital tools to achieve cost reduction and efficiency improvement[56] - The company changed the use of 44.124 million yuan in raised funds from the "chain pharmacy expansion project" to the "digital system upgrade construction project" to enhance digital capabilities[55] - The company is promoting the integration of industry and trade, focusing on high-end fertilizer and pesticide manufacturing, agricultural service projects, and technological innovation to increase product added value[53] - The company is implementing a new agricultural production service model, combining land remediation, modern agricultural demonstration zone construction, and socialized services under the EPC+O model[53] - The company is focusing on the development of traditional Chinese medicine, aiming to create a "Zhejiang model" for the revitalization of the Chinese herbal medicine industry through high-quality and premium pricing strategies[54] - The company is strengthening its core competitiveness in agricultural services by enhancing independent R&D capabilities, mastering core technologies, and building its own brand[54] - The company's agricultural comprehensive service business has ranked in the top three of the "Annual China Agricultural Materials Circulation Enterprise Comprehensive Competitiveness Top 100" for 13 consecutive years, with the past two years entering the top two, demonstrating strong competitive advantages and high industry status[60] - The company is accelerating the construction of a 10,000-ton traditional Chinese medicine decoction piece expansion project and a technology R&D center project, with the decoction piece project currently at 43.03% completion and the R&D center project at 78.37% completion[62] - The company's pharmaceutical logistics phase II project has been completed with an investment progress of 96.77%, and the pharmaceutical wholesale business expansion project has reached 99.95% completion[62] - The digital system upgrade construction project has an investment progress of 10.75% and is expected to improve management and operational efficiency, optimize resource allocation, and promote long-term strategic development[62] - The company is actively seeking high-quality M&A opportunities that align with the actual needs of its three major business segments, aiming to strengthen the supply chain and integrate resources in the agricultural materials circulation field[57] - The company is accelerating the construction of the Kaihua multifunctional comprehensive agricultural service project, aiming to build it into a high-end green fertilizer production and R&D base, manufacturing center, and provincial-level fertilizer reserve center[57] - The company's agricultural materials circulation business is influenced by the planting cycles of economic and grain crops, with the peak sales season occurring from March to October each year[60] - The company's agricultural comprehensive service business is expected to benefit from the national strategy of building a strong agricultural country and the emphasis on rural revitalization and agricultural modernization[63] - The company's digital system upgrade construction project does not directly generate revenue and cannot be separately accounted for in terms of benefits[61] - The company's agricultural materials circulation industry is characterized by a "large industry, small enterprise" structure, with industry concentration expected to gradually increase as the industry transitions from traditional agricultural materials trading to comprehensive agricultural social services[63] - The market penetration rate of new energy vehicles in China reached 25.6% in 2022, an increase of 12.1 percentage points compared to the previous year[65] - The company ranked 61st in the 2021 China Pharmaceutical Retail Top 100 Enterprises, up from 65th in the previous year[65] - The company has established nearly 3,000 agricultural material retail outlets nationwide, with a strong presence in Zhejiang Province[69] - The company operates 101 direct agricultural material retail outlets, primarily in Zhejiang, Jiangsu, Jiangxi, Anhui, Hunan, and Fujian[70] - The company has established six fertilizer production plants in Zhejiang, Jiangsu, Anhui, and Liaoning provinces[69] - The company has built a global sourcing network and maintains long-term strategic partnerships with major domestic and international agricultural material producers[69] - The company is exploring a new EPC+O business model integrating land remediation, modern agricultural demonstration zone construction, and socialized services[69] - The company is developing a full industrial chain model for traditional Chinese medicine, focusing on "Zhe Ba Wei" medicinal herbs[69] - The company's pharmaceutical business integrates wholesale, retail, production, logistics, and medical services, with a strong focus on Shaoxing and surrounding areas[70] - The company has established long-term strategic partnerships with internationally renowned agricultural material brands, ensuring access to key resources[70] - The company operates 33 standardized car 4S stores in Zhejiang and Jiangsu provinces, focusing on luxury brands such as BMW, Audi, and Cadillac[71] - The company's pharmaceutical retail business has 105 retail stores, primarily located in rural areas of Shaoxing, Zhejiang, giving it a unique competitive advantage[71] - In 2022, the company's automotive retail business generated revenue of 1.64 billion yuan, with 1.40 billion yuan from Zhejiang province and 234.87 million yuan from Jiangsu province[75] - The company added 8 new pharmaceutical retail stores in 2022, increasing revenue by 509.45 million yuan[75] - The company's automotive retail business added 2 new 4S stores in 2022, increasing revenue by 187.91 million yuan[75] - The top-performing automotive retail store, Zhejiang Jinhu Electromechanical Co., Ltd., generated revenue of 159.09 million yuan in 2022[75] - The company's pharmaceutical retail business in Zhejiang province achieved a sales growth rate of 7.04% in 2022[75] - The company's pharmaceutical retail business outside Zhejiang province achieved a sales growth rate of 48.43% in 2022[75] - The company's automotive retail business in Zhejiang province achieved a revenue of 1.40 billion yuan in 2022, with an average revenue per square meter of 1.76 million yuan[75] - The company's automotive retail business outside Zhejiang province achieved a revenue of 234.87 million yuan in 2022, with an average revenue per square meter of 4.65 million yuan[75] - The top-performing store, Yuecheng Jingyuetang Traditional Chinese Medicine Hall, generated revenue of 87.71 million yuan in 2022[76] - The average sales growth rate in Zhejiang Province was 7.11%, with comparable revenue increasing from 38,912.00 million yuan in 2021 to 42,077.74 million yuan in 2022[77] - The total revenue from agricultural retail stores in Zhejiang Province was 180,780.66 million yuan, with 38 stores covering an area of 102,704.29 m²[78] - The revenue per square meter for agricultural retail stores in Zhejiang Province was 6.07 million yuan/m², slightly decreasing by 0.01% compared to 2021[79] - The company's pharmaceutical retail business in Zhejiang Province generated revenue of 42,077.74 million yuan from 102 stores covering 13,090.40 m²[79] - The company has maintained a top-three position in China's agricultural materials circulation enterprise competitiveness ranking since 2010, recently moving up to second place[80] - The company's automotive trade and service business ranks among the top in BMW dealer groups, with multiple 4S stores receiving BMW Excellent Dealer awards[80] - The company's pharmaceutical wholesale and retail businesses are both ranked among the top 100 in China according to Ministry of Commerce statistics[80] - Revenue for the reporting period reached 41.81 billion yuan, an increase of 18.97% year-on-year[86] - Net profit attributable to shareholders of the listed company was 609.79 million yuan, a decrease of 7.11% year-on-year[86] - The company completed 200,000 tons of national fertilizer commercial reserves and 120,000 tons of provincial fertilizer off-season reserves[84] - The company established and operated 18 agricultural service centers in Zhejiang Province[84] - The company's "Zhenong Yun" brand was officially launched in August 2022, focusing on building an agricultural service ecosystem[85] - The company's agricultural comprehensive service business achieved high-quality growth, with revenue proportion continuing to rise[85] - The company's pharmaceutical production and sales business expanded rapidly, benefiting from increased demand and the development of traditional Chinese medicine formula granule business[86] - The company's automotive trade business experienced a decline in revenue and profit due to supply chain impacts and changes in the automotive market consumption structure[86] - The company's agricultural service model innovation included the exploration of a full-chain "land remediation + modern agricultural demonstration zone construction + socialized service" EPC+O model[87] - The company established a 500-acre Hangzhou white chrysanthemum base as part of its pilot project for the development of the entire Chinese herbal medicine industry chain[87] - Total revenue in 2022 reached 41.81 billion yuan, a year-on-year increase of 18.97%[93] - Agricultural comprehensive service revenue increased by 40.94% to 23.34 billion yuan, accounting for 55.81% of total revenue[93] - Automotive trade service revenue decreased by 2.34% to 16.59 billion yuan, accounting for 39.67% of total revenue[93] - Pharmaceutical production and sales revenue increased by 17.88% to 1.89 billion yuan, accounting for 4.52% of total revenue[93] - Fertilizer sales revenue increased by 50.21% to 18.47 billion yuan, accounting for 44.18% of total revenue[93] - Revenue from Zhejiang Province accounted for 64.18% of total revenue, reaching 26.84 billion yuan, a year-on-year increase of 14.55%[93] - Revenue from outside Zhejiang Province increased by 27.82% to 14.98 billion yuan, accounting for 35.82% of total revenue[93] - Direct sales revenue increased by 21.84% to 30.99 billion yuan, accounting for 74.12% of total revenue[93] - Distribution sales revenue increased by 11.46% to 10.82 billion yuan, accounting for 25.88% of total revenue[93] - The company added 107 new formula granule customers and obtained 225 formula granule production record numbers in the province and 807 outside the province[91] - Agricultural comprehensive service revenue increased by 40.94% to 23.34 billion RMB, with fertilizer revenue growing by 50.21% to 18.47 billion RMB[95][98] - Automotive trade service revenue decreased by 2.34% to 16.59 billion RMB, with vehicle sales revenue dropping by 1.59% to 14.03 billion RMB[95][98] - Gross profit margin for agricultural comprehensive service decreased by 1.00% to 5.75%, while automotive trade service gross profit margin decreased by 1.71% to 9.40%[95] - Fertilizer procurement costs increased by 53.31% due to rising international commodity prices, contributing to a 42.46% increase in agricultural service operating costs[95][97] - Revenue from Zhejiang province increased by 14.55% to 26.84 billion RMB, while revenue from outside Zhejiang increased by 27.82% to 14.98 billion RMB[95] - Direct sales revenue